researchers aim to develop a molecular understanding of the role that epigenetic regulators play in the initiation and maintenance of cancer and uncover the epigenetic mechanisms by which malignancies evade therapeutic pressure. Our priority is to translate these discoveries into personalised approaches that advance clinical care.